122 related articles for article (PubMed ID: 38911744)
21. Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics.
Rovina D; Fontana L; Monti L; Novielli C; Panini N; Sirchia SM; Erba E; Magnani I; Larizza L
Eur J Cell Biol; 2014; 93(8-9):355-65. PubMed ID: 25123532
[TBL] [Abstract][Full Text] [Related]
22. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
[TBL] [Abstract][Full Text] [Related]
23. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
[TBL] [Abstract][Full Text] [Related]
24. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
Trinczek B; Brajenovic M; Ebneth A; Drewes G
J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
[TBL] [Abstract][Full Text] [Related]
25. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
[TBL] [Abstract][Full Text] [Related]
26. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
[TBL] [Abstract][Full Text] [Related]
27. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
[TBL] [Abstract][Full Text] [Related]
28. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
[TBL] [Abstract][Full Text] [Related]
29. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
[TBL] [Abstract][Full Text] [Related]
31. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases.
Alam M; Ahmed S; Abid M; Hasan GM; Islam A; Hassan MI
J Cell Biochem; 2023 Sep; 124(9):1223-1240. PubMed ID: 37661636
[TBL] [Abstract][Full Text] [Related]
34. Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.
Naz F; Islam A; Ahmad F; Hassan MI
Mol Cell Biochem; 2015 Dec; 410(1-2):223-8. PubMed ID: 26346160
[TBL] [Abstract][Full Text] [Related]
35. PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression
Li F; Liu Z; Sun H; Li C; Wang W; Ye L; Yan C; Tian J; Wang H
Acta Pharm Sin B; 2020 Feb; 10(2):289-300. PubMed ID: 32082974
[TBL] [Abstract][Full Text] [Related]
36. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
[TBL] [Abstract][Full Text] [Related]
37. Microtubule affinity-regulating kinase 4: structure, function, and regulation.
Naz F; Anjum F; Islam A; Ahmad F; Hassan MI
Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664
[TBL] [Abstract][Full Text] [Related]
38. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
39. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis.
Qin YS; Li H; Wang SZ; Wang ZB; Tang CK
J Cell Physiol; 2022 Jan; 237(1):86-97. PubMed ID: 34289095
[TBL] [Abstract][Full Text] [Related]
40. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
